Characterizing the specific downstream signaling pathways of FGFR1 and these pathway-regulated key genes responsible for mediating FGFR1-promoted breast cancer growth will help to identify alternative molecular targets for developing new therapies. The gene discussed is FGFR1; the disease is breast carcinoma.